Brinks Co
NYSE:BCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brinks Co
NYSE:BCO
|
US |
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
CDW Corp
NASDAQ:CDW
|
US |
Wall St Price Targets
BCO Price Targets Summary
Brinks Co
According to Wall Street analysts, the average 1-year price target for BCO is 157.08 USD with a low forecast of 146.45 USD and a high forecast of 171.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BCO's stock price target?
Price Target
157.08
USD
According to Wall Street analysts, the average 1-year price target for BCO is 157.08 USD with a low forecast of 146.45 USD and a high forecast of 171.15 USD.
What is the Revenue forecast for Brinks Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Brinks Co?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Brinks Co?
Projected CAGR
39%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 39%.
